New patent for Adamas Operations drug OSMOLEX ER
Annual Drug Patent Expirations for OSMOLEX+ER Osmolex Er is a drug marketed by Adamas Operations and is included in one […]
New patent for Adamas Operations drug OSMOLEX ER Read Post »
Annual Drug Patent Expirations for OSMOLEX+ER Osmolex Er is a drug marketed by Adamas Operations and is included in one […]
New patent for Adamas Operations drug OSMOLEX ER Read Post »
Annual Drug Patent Expirations for KERENDIA Kerendia is a drug marketed by Bayer Hlthcare and is included in one NDA.
Annual Drug Patent Expirations for OLUMIANT Olumiant is a drug marketed by Eli Lilly And Co and is included in
Annual Drug Patent Expirations for BAFIERTAM Bafiertam is a drug marketed by Banner Life Sciences and is included in one
Annual Drug Patent Expirations for LYNPARZA Lynparza is a drug marketed by Astrazeneca and is included in two NDAs. It
Annual Drug Patent Expirations for PREVYMIS Prevymis is a drug marketed by Merck Sharp Dohme and is included in two
Annual Drug Patent Expirations for KYLEENA Kyleena is a drug marketed by Bayer Hlthcare and is included in one NDA.
Annual Drug Patent Expirations for MIRENA Mirena is a drug marketed by Bayer Hlthcare and is included in one NDA.
Annual Drug Patent Expirations for SKYLA Skyla is a drug marketed by Bayer Hlthcare and is included in one NDA.
Get fresh news and insights, drug patent expirations & more…